Paper37656237
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges.
Zheng H and 11 others. Cell Regen, 2023. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges. Papers, record 37656237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37656237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022YFA1103500 | National Key Research and Development Program of China | PubMed | ||
| 8220010141 | Natural Science Foundation of China | PubMed | ||
| 92268117 | Natural Science Foundation of China | PubMed | ||
| 82161138028 | Natural Science Foundation of China | PubMed | ||
| 82200233 | Natural Science Foundation of China | PubMed | ||
| 82222003 | Natural Science Foundation of China | PubMed | ||
| LQ22H080005 | Zhejiang Provincial Natural Science Foundation of China | PubMed | ||
| SZSM202111004 | Sanming Project of Medicine in Shenzhen | PubMed | ||
| 2020R01006 | Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 37807020 | Correction: Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges. | https://conductscience.org/library/papers/37807020 |
Source PubMed
References202
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20154732 | Blood stem cells emerge from aortic endothelium by a novel type of cell transition. | Nature | 2010 | https://conductscience.org/library/papers/20154732 | PubMed |
| 2 | 30574146 | Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells. | Front Immunol | 2018 | https://conductscience.org/library/papers/30574146 | PubMed |
| 3 | 34695489 | Human stem cell-derived thymic epithelial cells enhance human T-cell development in a xenogeneic thymus. | J Allergy Clin Immunol | 2022 | https://conductscience.org/library/papers/34695489 | PubMed |
| 4 | 22901265 | Hematopoietic stem cell expansion: challenges and opportunities. | Ann N Y Acad Sci | 2012 | https://conductscience.org/library/papers/22901265 | PubMed |
| 5 | 23670574 | Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. | Mol Ther | 2013 | https://conductscience.org/library/papers/23670574 | PubMed |
| 6 | 34045451 | Human stem cells harboring a suicide gene improve the safety and standardisation of neural transplants in Parkinsonian rats. | Nat Commun | 2021 | https://conductscience.org/library/papers/34045451 | PubMed |
| 7 | 21343360 | Embryonic origin of the adult hematopoietic system: advances and questions. | Development | 2011 | https://conductscience.org/library/papers/21343360 | PubMed |
| 8 | 34831472 | Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies. | Cells | 2021 | https://conductscience.org/library/papers/34831472 | PubMed |
| 9 | 15528136 | Human bone marrow CD34+ progenitor cells mature to T cells on OP9-DL1 stromal cell line without thymus microenvironment. | Blood Cells Mol Dis | 2004 | https://conductscience.org/library/papers/15528136 | PubMed |
| 10 | 23212524 | In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. | Blood | 2013 | https://conductscience.org/library/papers/23212524 | PubMed |
| 11 | 36929134 | Multiple waves of fetal-derived immune cells constitute adult immune system. | Immunol Rev | 2023 | https://conductscience.org/library/papers/36929134 | PubMed |
| 12 | 30449714 | Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy. | Cell Stem Cell | 2018 | https://conductscience.org/library/papers/30449714 | PubMed |
| 13 | 27422351 | Efficient Regeneration of Human Vα24+ Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo. | Stem Cells | 2016 | https://conductscience.org/library/papers/27422351 | PubMed |
| 14 | 23826321 | Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft models. | PLoS One | 2013 | https://conductscience.org/library/papers/23826321 | PubMed |
| 15 | 31839543 | Inducible Forward Programming of Human Pluripotent Stem Cells to Hemato-endothelial Progenitor Cells with Hematopoietic Progenitor Potential. | Stem Cell Reports | 2020 | https://conductscience.org/library/papers/31839543 | PubMed |
| 16 | 32221280 | Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain. | Nat Commun | 2020 | https://conductscience.org/library/papers/32221280 | PubMed |
| 17 | 28676567 | Human haematopoietic stem cell development: from the embryo to the dish. | Development | 2017 | https://conductscience.org/library/papers/28676567 | PubMed |
| 18 | 18566957 | Recent advances in three-dimensional multicellular spheroid culture for biomedical research. | Biotechnol J | 2008 | https://conductscience.org/library/papers/18566957 | PubMed |
| 19 | 24362021 | Preclinical studies for induced pluripotent stem cell-based therapeutics. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24362021 | PubMed |
| 20 | 33656760 | Vitronectin-activated αvβ3 and αvβ5 integrin signalling specifies haematopoietic fate in human pluripotent stem cells. | Cell Prolif | 2021 | https://conductscience.org/library/papers/33656760 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42495614 | HIDmap: a physiology-based map of human immune system development to support animal-free research and regulatory innovation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42495614 | PubMed |
| 42367075 | The mitochondria-targeting compound PTC299 enhances megakaryocyte and platelet production. | Stem Cells Transl Med | 2026 | https://conductscience.org/library/papers/42367075 | PubMed |
| 42321817 | Retinoic acid as a stage-specific modulator of hematopoietic lineage fate from human pluripotent stem cells. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42321817 | PubMed |
| 42144533 | CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42144533 | PubMed |
| 42079015 | New approach methodologies (NAMs) to support regulatory assessment of developmental immunotoxicity - a new PARC project. | Front Toxicol | 2026 | https://conductscience.org/library/papers/42079015 | PubMed |
| 41998287 | A transgene-free, human peri-gastrulation embryo model presents trilaminar embryonic disc-, amnion- and yolk sac-like structures. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/41998287 | PubMed |
| 41492495 | P-LM421E8, the heparan sulfate chain-conjugated laminin-421-E8 fragment, drives differentiation of human induced pluripotent stem cells into hematopoietic progenitor cells comparable to basic fibroblast growth factor in a chemically defined system. | Matrix Biol Plus | 2026 | https://conductscience.org/library/papers/41492495 | PubMed |
| 40913820 | Stability testing of HPCs and MNCs from apheresis products. | Immunobiology | 2025 | https://conductscience.org/library/papers/40913820 | PubMed |
| 40868263 | Induced Pluripotent Stem Cell-Based Cancer Immunotherapy: Strategies and Perspectives. | Biomedicines | 2025 | https://conductscience.org/library/papers/40868263 | PubMed |
| 40723215 | Animal Venoms as Potential Antitumor Agents Against Leukemia and Lymphoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40723215 | PubMed |
| 40704043 | Culturing Potential: advances in ex vivo cell culture systems for haematopoietic cell-based regenerative therapies. | Regen Ther | 2025 | https://conductscience.org/library/papers/40704043 | PubMed |
| 40598222 | BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesis. | J Hematol Oncol | 2025 | https://conductscience.org/library/papers/40598222 | PubMed |
| 40587040 | Hematopoietic stem cells and HSCs-derived from pluripotent stem cells: a hopeful outlook in cell-based therapeutics. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40587040 | PubMed |
| 40484698 | Temporal Regulation of Cytokines and Growth Factors for Optimized Hematopoietic-Lineage Specification from Human Pluripotent Stem Cells. | Int J Stem Cells | 2025 | https://conductscience.org/library/papers/40484698 | PubMed |
| 40423909 | Cell-based artificial platelet production: historical milestones, emerging trends, and future directions. | Blood Res | 2025 | https://conductscience.org/library/papers/40423909 | PubMed |
| 40243850 | Microgravity and Cellular Biology: Insights into Cellular Responses and Implications for Human Health. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40243850 | PubMed |
| 40185089 | Competing dynamic gene regulatory networks involved in fibroblast reprogramming to hematopoietic progenitor cells. | Stem Cell Reports | 2025 | https://conductscience.org/library/papers/40185089 | PubMed |
| 39894817 | Forward programming of hPSCs to neutrophils using chemically defined media. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/39894817 | PubMed |
| 39624236 | Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39624236 | PubMed |
| 39533434 | Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/39533434 | PubMed |
Genes91
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37656237
GET https://conductscience.org/api/papers/v1/37656237/references?page=2